CIBC Private Wealth Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$196K Buy
1,918
+16
+0.8% +$1.43K ﹤0.01% 1203
2025
Q3
$119K Hold
1,902
﹤0.01% 1421
2025
Q2
$99K Buy
1,902
+1,835
+2,739% +$82K ﹤0.01% 1389
2025
Q1
$2.67K Sell
67
-177
-73% -$7.64K ﹤0.01% 2622
2024
Q4
$8.93K Hold
244
﹤0.01% 2302
2024
Q3
$5.6K Sell
244
-300
-55% -$8.49K ﹤0.01% 2565
2024
Q2
$15K Sell
544
-32
-6% -$745 ﹤0.01% 2145
2024
Q1
$11.7K Buy
+576
New +$12.3K ﹤0.01% 2220
2022
Q3
Sell
-4
Closed 1014
2022
Q2
$0 Buy
+4
New +$198 ﹤0.01% 1237

Other funds holding GH

CIBC Private Wealth Group's GH Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Guardant Health (GH) stake by 0.84% in Q4 2025, buying an estimated $1.43K and bringing the position to 1,918 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #1203.

CIBC Private Wealth Group first reported a position in GH in Q2 2022 and has held it in 9 quarters since. 495 funds tracked by Wall St. Rank hold GH as of Q4 2025.

  • CIBC Private Wealth Group held 1,918 shares of Guardant Health worth $196K as of Q4 2025.
  • CIBC Private Wealth Group bought 16 Guardant Health shares in Q4 2025, an estimated $1.43K.
  • Guardant Health made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1203 holding.
  • CIBC Private Wealth Group first reported a position in Guardant Health in Q2 2022 and has held it in 9 quarters since.
  • 495 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.